EQS-News: New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved GFR Estimation in Steady-State and Critically Ill Patients

Issuer: SphingoTec GmbH / Key word(s): Research Update/Study results New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved GFR Estimation in Steady-State and Critically Ill Patients 05.10.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. P...

Related Keywords

Netherlands ,Berlin ,Germany ,Hennigsdorf ,Brandenburg ,United States ,Sphingotec Gmbh ,Ruxandra Lenz ,Florian Uhle ,Sphingotec Gmb ,Pickkerset Al ,Research Update Study ,Radboud University ,Disease Quality Initiative ,Adm ,Distribution Services ,Peter Pickkers Head Of Research ,Radboud University Medical Centre ,Kidney International ,Formula Leverages Proenkephalin ,Critically Ill Patients ,Mayo Clinic ,Peter Pickkers ,Intensive Care Medicine ,Radboud University Nijmegen Medical Centre ,Medical Director ,Kidney International Reports ,Acute Disease Quality Initiative ,Nature Reviews Nephrology ,Intensive Care Med Exp ,Tec Gmbh ,Corporate News ,Regulatory Announcements ,Update Study ,Few ,Formula ,Beverages ,Roenkephalin , ,Mproved ,Fr ,Estimation ,Steady State ,Critically ,Wall ,Patients ,Et Cest ,The ,